Structure based virtual screening and molecular simulation study of FDA-approved drugs to inhibit human HDAC6 and VISTA as dual cancer immunotherapy
Article in Scientific Reports (September 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Scientific Reports (September 2023)
Article in Frontiers in Medicine (July 2023)